tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMCR Stock Latest News

Immunocore Holdings: Buy Rating Backed by Promising Strategy and Strong Financials Despite Mixed Study Data
RatingsImmunocore Holdings: Buy Rating Backed by Promising Strategy and Strong Financials Despite Mixed Study Data
2d ago
IMCR
Immunocore Holdings’ Promising HIV Immunotherapy Advances Justify Buy Rating
PremiumRatings
Immunocore Holdings’ Promising HIV Immunotherapy Advances Justify Buy Rating
3d ago
IMCR
Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
PremiumRatings
Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
4d ago
IMCR
Immunocore Holdings Reveals Promising HIV Trial Results
PremiumCompany Announcements
Immunocore Holdings Reveals Promising HIV Trial Results
4d ago
8K
IMCR
Immunocore assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Immunocore assumed with an Equal Weight at Morgan Stanley
8d ago
IMCR
Immunocore Holdings: Pioneering HIV Cure with Promising Phase 1 STRIVE Trial Results
PremiumRatingsImmunocore Holdings: Pioneering HIV Cure with Promising Phase 1 STRIVE Trial Results
10d ago
IMCR
Immunocore Reports 2024 Growth and Strategic Advances
Premium
Company Announcements
Immunocore Reports 2024 Growth and Strategic Advances
14d ago
IMCR
Immunocore’s Strategic Expansion and Robust Pipeline Drive Buy Rating
Premium
Ratings
Immunocore’s Strategic Expansion and Robust Pipeline Drive Buy Rating
15d ago
IMCR
Immunocore Holdings: Positive Earnings Call Highlights Growth
PremiumCompany Announcements
Immunocore Holdings: Positive Earnings Call Highlights Growth
15d ago
IMCR
Immunocore price target lowered to $85 from $88 at Oppenheimer
PremiumThe Fly
Immunocore price target lowered to $85 from $88 at Oppenheimer
16d ago
IMCR
Immunocore Holdings: Strong KIMMTRAK Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Immunocore Holdings: Strong KIMMTRAK Performance and Promising Pipeline Justify Buy Rating
16d ago
IMCR
Immunocore Holdings Faces Trade Secret Challenges Amid Global Competition
PremiumCompany Announcements
Immunocore Holdings Faces Trade Secret Challenges Amid Global Competition
16d ago
IMCR
Immunocore Holdings: Strong Kimmtrak Sales and Promising Pipeline Support Buy Rating
PremiumRatingsImmunocore Holdings: Strong Kimmtrak Sales and Promising Pipeline Support Buy Rating
17d ago
IMCR
Immunocore Holdings: Sustained Growth and Promising Pipeline Drive Positive Outlook
Premium
Ratings
Immunocore Holdings: Sustained Growth and Promising Pipeline Drive Positive Outlook
17d ago
IMCR
Immunocore Holdings Appoints William Pao as Director
Premium
Company Announcements
Immunocore Holdings Appoints William Pao as Director
17d ago
8K
IMCR
Immunocore reports Q4 EPS (47c), consensus (16c)
PremiumThe Fly
Immunocore reports Q4 EPS (47c), consensus (16c)
17d ago
IMCR
IMCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IMCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
IMCR
Immunocore Holdings Outlines Strategic Priorities for 2025
PremiumCompany Announcements
Immunocore Holdings Outlines Strategic Priorities for 2025
2M ago
8K
IMCR
Immunocore reports cash, equivalents of $820M as of December 31
PremiumThe Fly
Immunocore reports cash, equivalents of $820M as of December 31
2M ago
IMCR
Immunocore announces 2025 strategic priorities at JPM Conference
PremiumThe FlyImmunocore announces 2025 strategic priorities at JPM Conference
2M ago
IMCR
Immunocore Holdings Strengthens Leadership with Key Appointment
Premium
Company Announcements
Immunocore Holdings Strengthens Leadership with Key Appointment
2M ago
8K
IMCR
Immunocore appoints Travis Coy as CFO and Head of Corporate Development
Premium
The Fly
Immunocore appoints Travis Coy as CFO and Head of Corporate Development
2M ago
IMCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >